The Ethics and Security Challenge of Gene Editing

June 26, 2023

Georgetown Journal of International Affairs

“The weaponization of the scientific and technological breakthroughs stemming from human genome research presents a serious global security challenge. Gene-editing pioneer and Nobel Laureate Jennifer Doudna often tells a story of a nightmare she once had. A colleague asked her to teach someone how her technology works. She went to meet the student and ‘was shocked to see Adolf Hitler, in the flesh.’

Doudna is not alone in being haunted by the power of science. Famously, having just returned home from Los Alamos in early 1945, John von Neumann awakened in panic. ‘What we are creating now is a monster whose influence is going to change history, provided there is any history left,’ he stammered while straining to speak to his wife. He surmised, however, that ‘it would be impossible not to see it through, not only for military reasons, but it would also be unethical from the point of view of the scientists not to do what they knew is feasible, no matter what terrible consequences it may have.'”

SMA Speaker Series: Ethical and National Security Implications of Genetic Weapons

May 24, 2023

Strategic Multilayer Assessment (SMA) General Speaker Session

“At times, biotechnology appears to blend science fiction and reality. The potential warfighting applications of biotechnology and the size of the bioeconomy has made biotechnology a focus point of the US-China rivalry. Dr. Biberman described the different steps and viewpoints of both nations relating to biotechnology and bioengineered weaponry. Since 2006, Chinese military officials have commented on the potential benefits of integrating biotechnology into the armed forces. A current perception is that China is one step ahead of the US. China focused on military-civil fusion during the 1990s and developed a five-year bioeconomic plan for 2021-2025. However, Dr. Biberman clarified that the US retains some dominance. The Biden Administration has acted to ensure the US remains ahead of China, including signing an executive order to advance biotechnology and biomanufacturing innovation. The order is designed to grow the US bioeconomy while also ensuring that this growth is achieved sustainably, safely, and ethically.”